ArticleBMC ophthalmology2026
Gelatinous drop-like amyloid in FOXC2 distichiasis syndrome: a case report.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGelatinous drop-like dystrophy is a rare autosomal recessive disorder caused by pathogenic variants in the TACSTD2 gene and characterized by subepithelial amyloid deposits in the cornea. Alterations in FOXC2 are seen in lymphedema-distichiasis syndrome, in which patients classically exhibit lymphedema of the extremities and a double row of eyelashes. This report links alterations in the FOXC2 gene to a corneal phenotype that is histologically identical to that seen in gelatinous drop-like dystrophy. CASE PRESENTATION: A 14-year-old male with congenital distichiasis presented with chronic photosensitivity and progressively worsening vision over several years. On examination, gelatinous-appearing lesions were observed on the inferior third of each cornea with neovascularization. Genetic testing identified a likely pathogenic alteration in FOXC2, a gene linked to lymphedema-distichiasis syndrome. No genetic alterations of corneal dystrophy were identified. The patient underwent excisions of the corneal lesions with simple limbal epithelial transplant, amniotic membrane transplant and temporary central tarsorrhaphy. The pathologic features of the corneal lesions resembled gelatinous drop-like dystrophy. One side was free of inflammation, while the other side showed a granulomatous response to the amyloid, which is unusual in this site. Potential pathogenic and clearance mechanisms are discussed. There has been no recurrence of the corneal lesions in approximately 3 years of follow-up.
conclusionsThis case presents a new link between FOXC2 alterations and a histological phenotype that resembles gelatinous drop-like dystrophy (GDLD-like), emphasizing the importance of clinical, pathologic, and molecular correlation. Granulomatous responses to amyloid are unusual in this immune privileged site.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.